Concordia Healthcare Corp (TSE:CXR) (NASDAQ:CXRX)‘s stock had its “sector perform” rating restated by Royal Bank Of Canada in a research note issued on Monday, StockTargetPrices.com reports. They currently have a C$3.50 price objective on the stock. Royal Bank Of Canada’s price objective suggests a potential downside of 1.41% from the stock’s current price.
A number of other equities analysts have also recently issued reports on the company. Bloom Burton cut Concordia Healthcare Corp from a “hold” rating to a “sell” rating in a report on Monday, November 7th. TD Securities boosted their price objective on Concordia Healthcare Corp from C$7.00 to C$14.00 and gave the company a “hold” rating in a report on Monday, September 19th. Goldman Sachs Group Inc. dropped their price objective on Concordia Healthcare Corp from C$34.00 to C$17.00 in a report on Monday, August 15th. Finally, CIBC cut Concordia Healthcare Corp from a “sector perform” rating to an “underperform” rating in a report on Monday, August 15th. Two investment analysts have rated the stock with a sell rating and four have issued a hold rating to the company. The stock presently has an average rating of “Hold” and an average target price of C$23.63.
Shares of Concordia Healthcare Corp (TSE:CXR) traded down 1.13% during trading on Monday, hitting $3.51. The stock had a trading volume of 147,571 shares. Concordia Healthcare Corp has a 12 month low of $2.27 and a 12 month high of $28.35. The company’s market cap is $179.07 million. The stock has a 50-day moving average price of $4.47 and a 200 day moving average price of $17.59.
Concordia Healthcare Corp Company Profile